Physical rehabilitation and risk of atherosclerosis after successful kidney transplantation

Transplantation Proceedings

Volumn 38, Issue 1, 2006, Pages 157-160

  Juskowa, J ^a   Lewandowska, M ^a   Bartlomiejczyk I ^a   Foroncewicz, B ^a   Korabiewska, I ^a   Niewczas, M ^a   Sierdzinski J ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; HOMOCYSTEINE; INTERLEUKIN 18;

ADULT; ANALYSIS OF VARIANCE; ARM MUSCLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCLE TRAINING; PATIENT CARE; PHYSICAL ACTIVITY; PHYSIOTHERAPIST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STANDARD; TRAINING;

ADULT; ATHEROSCLEROSIS; EXERCISE; FEMALE; HOMOCYSTEINE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHYSICAL FITNESS;

EID: 33644500783     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.12.077     Document Type: Conference Paper

References (23)

1. P. Moons, Y. Vanrenterghem, J.P. van Hoof Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation a multicentre study Transpl Int 16 2003 653
2. S.M. Bartosh, G. Leverson, D. Robillard Long-term outcomes in pediatric renal transplant who survive into adulthood Transplantation 76 2003 1195
3. P. Bonetti, L. Lerman, A. Lerman Endothelial dysfunction. A marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 2003 168
4. S.H. Wilson, N.M. Caplice, R.D. Simari Activated nuclear factor-kB is present in the coronary vasculature in experimental hypercholesterolemia Atherosclerosis 148 2000 23
5. P.L. Painter, L. Hector, K. Ray A randomized trial of exercise training after renal transplantation Transplantation 74 2002 42
6. M.J. Burne-Taney, N. Yokata, H. Rabb Persistent renal and extrarenal immune changes after severe ischemic injury Kidney Int 67 2005 1002
7. E.C. Pavarino-Bertelli, M.P. Sanches de Alvarenga, E.M. Goloni-Bertollo Hyperhomocysteinemia and MTHFR C 677T and A 1298 polymorphisms are associated with chronic allograft nephropathy in renal transplant recipients Transplant Proc 36 2004 2979
8. M. Merkel Homocysteine as a risk factor of cardiovascular disease International Congress Series 1262 2004 376
9. K.L. Johansen, T. Shubert, J. Doyle Muscle atrophy in patients receiving hemodialysis effects on muscle strength, muscle quality and physical function Kidney Int 63 2003 291
10. A. Covic, N. Mardare, P. Gusbeth-Tatomir Acute effect of Cy A (Neoral) on large artery hemodynamics in renal transplant patients Kidney Int 67 2005 732
11. P.L. Painter, L. Hector, K. Ray Effects of exercise training on coronary heart disease risk factors in renal transplant recipients Am J Kidney Dis 42 2003 362
12. Y.-T. Minako, T. Taiki, I. Takayuki Circulating levels of interleukin-18 reflect etiologies of heart failure Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure J Cardiac Failure 8 2002 21
13. V. Sepe, C. Libetta, G. Villa Correlation between hyperhomocysteinemia and interleukin-18 serum levels in maintenance hemodialyzed patients Kidney Int 62 2002 1900
14. Z. Mallat, A. Corbaz, A. Scoazec Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability Circulation 104 2001 1598
15. A. Yoshimasa, O. Ki-ichi, T. Kohzo Corelationship of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes Diabetes Care 26 2003 2622
16. J. Juskowa, I. Bartłomiejczyk, L. PaCombining ogonekczek Total homocysteine as a risk factor for vascular disease in renal transplant recipients Transplant Proc 34 2002 576
17. V. Taplan, O. Schuck, M. Stollova Obesity hyperhomocysteinemia after kidney transplantation Nephrol Dial Transplant 18 2003 71
18. M. Busch, S. Franke, A. Müller Potential cardiovascular risk factors in chronic kidney disease AGEs total homocysteine and metabolites and the C-reactive proteins Kidney Int 66 2004 338
19. K.A. Hajjar Homocysteine a sulphorous fire J Clin Invest 107 2001 664
20. K. Kalantar-Zadeh, G. Block, M.H. Humphreys A low rather than a high total plasma homocysteine is an indicator of poor outcome in hemodialysis patients J Am Soc Nephrol 15 2004 442
21. S. Gangemi, A. Mallamace, P.L. Minciuillo Involvement of interleukin-18 in patients on maintenance hemodialysis Am J Nephrol 22 2002 417
22. E. O'Riordan, J. Chen, S.V. Brodsky Endothelial cell dysfunction the syndrome in making Kidney Int 67 2005 1654
23. M.A. Hofmann, L. Evanthia, L. Yan Hyperhomocysteinemia enhances vascular, inflammation and accelerates atherosclerosis in a murine model J Clin Invest 107 2001 675